Atlas Trials

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Clinical trial NCT02408016 · TERMINATED

Trial details

NCT number
NCT02408016
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung CarcinomaRecurrent Pleural Malignant MesotheliomaStage III Non-Small Cell Lung Cancer AJCC v7Stage III Pleural Malignant Mesothelioma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7Stage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7Stage IV Pleural Malignant Mesothelioma AJCC v7WT1 Positive
Start date
2015-05-22
Primary completion
2020-06-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.